153 related articles for article (PubMed ID: 36167867)
21. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction.
Christie JD; Robinson N; Ware LB; Plotnick M; De Andrade J; Lama V; Milstone A; Orens J; Weinacker A; Demissie E; Bellamy S; Kawut SM
Am J Respir Crit Care Med; 2007 Jan; 175(1):69-74. PubMed ID: 17023732
[TBL] [Abstract][Full Text] [Related]
22. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.
Shah RJ; Diamond JM; Lederer DJ; Arcasoy SM; Cantu EM; Demissie EJ; Kawut SM; Kohl B; Lee JC; Sonett J; Christie JD; Ware LB
Transl Res; 2012 Dec; 160(6):435-42. PubMed ID: 22989614
[TBL] [Abstract][Full Text] [Related]
23. Atelectasis in primary graft dysfunction survivors after lung transplantation.
Li D; Abele J; Weinkauf J; Kapasi A; Hirji A; Varughese R; Nagendran J; Lien D; Doucette K; Halloran K
Clin Transplant; 2021 Jul; 35(7):e14315. PubMed ID: 33848359
[TBL] [Abstract][Full Text] [Related]
24. Influence of right ventricular function on the development of primary graft dysfunction after lung transplantation.
Pérez-Terán P; Roca O; Rodríguez-Palomares J; Sacanell J; Leal S; Solé J; Rochera MI; Román A; Ruiz-Rodríguez JC; Gea J; Evangelista A; Masclans JR
J Heart Lung Transplant; 2015 Nov; 34(11):1423-9. PubMed ID: 26169669
[TBL] [Abstract][Full Text] [Related]
25. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.
Hashimoto K; Cypel M; Kim H; Machuca TN; Nakajima D; Chen M; Hsin MK; Zamel R; Azad S; Waddell TK; Liu M; Keshavjee S
Am J Transplant; 2017 May; 17(5):1396-1404. PubMed ID: 27977885
[TBL] [Abstract][Full Text] [Related]
26. Blood Lactate During Double-Lung Transplantation: A Predictor of Grade-3 Primary Graft Dysfunction.
Fessler J; Vallée A; Guirimand A; Sage E; Glorion M; Roux A; Brugière O; Parquin F; Zuber B; Cerf C; Vasse M; Pascreau T; Fischler M; Ichai C; Guen ML
J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):794-804. PubMed ID: 34879926
[TBL] [Abstract][Full Text] [Related]
27. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
[TBL] [Abstract][Full Text] [Related]
28. Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation.
Hashimoto K; Besla R; Zamel R; Juvet S; Kim H; Azad S; Waddell TK; Cypel M; Liu M; Keshavjee S
Am J Respir Crit Care Med; 2016 Jul; 194(1):97-105. PubMed ID: 26796350
[TBL] [Abstract][Full Text] [Related]
29. Incidence of primary graft dysfunction is higher according to the new ISHLT 2016 guidelines and correlates with clinical and molecular risk factors.
Daoud D; Chacon Alberty L; Wei Q; Hochman Mendez C; Virk MHM; Mase J; Jindra P; Cusick M; Choi H; Debolske N; Sampaio LC; Taylor DA; Loor G
J Thorac Dis; 2021 Jun; 13(6):3426-3442. PubMed ID: 34277039
[TBL] [Abstract][Full Text] [Related]
30. Immediate post-operative broncho-alveolar lavage IL-6 and IL-8 are associated with early outcomes after lung transplantation.
Verleden SE; Martens A; Ordies S; Neyrinck AP; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
Clin Transplant; 2018 Apr; 32(4):e13219. PubMed ID: 29405435
[TBL] [Abstract][Full Text] [Related]
31. Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation.
Diamond JM; Cantu E; Porteous MK; Suzuki Y; Meyer KC; Lederer DJ; Milewski RK; Arcasoy S; D'Ovidio F; Bacchetta M; Sonett JR; Singh G; Costa J; Tobias JW; Rodriguez H; Van Deerlin VM; Olthoff KM; Shaked A; Chang BL; Christie JD;
Am J Transplant; 2017 Jul; 17(7):1770-1777. PubMed ID: 28117940
[TBL] [Abstract][Full Text] [Related]
32. Local complement activation is associated with primary graft dysfunction after lung transplantation.
Kulkarni HS; Ramphal K; Ma L; Brown M; Oyster M; Speckhart KN; Takahashi T; Byers DE; Porteous MK; Kalman L; Hachem RR; Rushefski M; McPhatter J; Cano M; Kreisel D; Scavuzzo M; Mittler B; Cantu E; Pilely K; Garred P; Christie JD; Atkinson JP; Gelman AE; Diamond JM
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32750037
[TBL] [Abstract][Full Text] [Related]
33. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
[TBL] [Abstract][Full Text] [Related]
34. Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion.
Boffini M; Ricci D; Bonato R; Fanelli V; Attisani M; Ribezzo M; Solidoro P; Del Sorbo L; Ranieri VM; Rinaldi M
Eur J Cardiothorac Surg; 2014 Nov; 46(5):789-93. PubMed ID: 25061216
[TBL] [Abstract][Full Text] [Related]
35. Effect of intraoperative support mode on circulating inflammatory biomarkers after lung transplantation surgery.
Chacon-Alberty L; Ye S; Elsenousi A; Hills E; King M; D'Silva E; Leon AP; Salan-Gomez M; Li M; Hochman-Mendez C; Loor G
Artif Organs; 2023 Apr; 47(4):749-760. PubMed ID: 36445099
[TBL] [Abstract][Full Text] [Related]
36. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.
Diamond JM; Kawut SM; Lederer DJ; Ahya VN; Kohl B; Sonett J; Palmer SM; Crespo M; Wille K; Lama VN; Shah PD; Orens J; Bhorade S; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
Am J Transplant; 2011 Mar; 11(3):561-7. PubMed ID: 21299834
[TBL] [Abstract][Full Text] [Related]
37. The role of lung microbiota in primary graft dysfunction in lung transplant recipients.
Wu Y; Huang L; Li M; Cui X; Zhan Q; Wang C
Clin Transplant; 2023 Dec; 37(12):e15152. PubMed ID: 37788167
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Survival Following Primary Graft Dysfunction Development in Lung Transplantation.
Gouchoe DA; Whitson BA; Rosenheck J; Henn MC; Mokadam NA; Ramsammy V; Kirkby S; Nunley D; Ganapathi AM
J Surg Res; 2024 Apr; 296():47-55. PubMed ID: 38219506
[TBL] [Abstract][Full Text] [Related]
39. Effect of mode of intraoperative support on primary graft dysfunction after lung transplant.
Loor G; Huddleston S; Hartwig M; Bottiger B; Daoud D; Wei Q; Zhang Q; Ius F; Warnecke G; Villavicencio MA; Tirabassi B; Machuca TN; Van Raemdonck D; Frick AE; Neyrinck A; Toyoda Y; Kashem MA; Landeweer M; Chandrashekaran S
J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1351-1361.e4. PubMed ID: 35236625
[TBL] [Abstract][Full Text] [Related]
40. C1-esterase-inhibitor for primary graft dysfunction in lung transplantation.
Sommer W; Tudorache I; Kühn C; Avsar M; Salman J; Ius F; Gras C; Weber P; Welte T; Gottlieb J; Haverich A; Warnecke G
Transplantation; 2014 Jun; 97(11):1185-91. PubMed ID: 24573112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
